Concord Biotech Board to Consider Bonus Shares on Sep 23

Concord Biotech Ltd has announced that its Board of Directors will convene on September 23, 2026, to consider and approve a proposal for the declaration of bonus equity shares to existing shareholders. This decision is subject to shareholder approval. Additionally, the company has closed its trading window for designated persons and their relatives from September 19, 2026, until 48 hours after the board meeting's outcome, reopening on September 26, 2026, in compliance with SEBI regulations.